Cancer Segment Likely First Market For Roche’s SynergysDx Program
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is anticipating that the drive to commercialize pharmacogenomic technology will create a need for coordinated drug and diagnostic premarket efforts, triggering increased demand for development partnerships between the two sectors